Drug Approval | March 28, 2024
Biocon to obtain approval for diabetes drug, Liraglutide in UK
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Vision loss due to Glaucoma can be prevented if it is detected and treated early
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
Subscribe To Our Newsletter & Stay Updated
